These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 19466393)
1. Involvement of alpha1-adrenoceptors in conditioned place preference supported by nicotine in rats. Forget B; Hamon M; Thiébot MH Psychopharmacology (Berl); 2009 Aug; 205(3):503-15. PubMed ID: 19466393 [TBL] [Abstract][Full Text] [Related]
2. Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats. Forget B; Hamon M; Thiébot MH Psychopharmacology (Berl); 2005 Oct; 181(4):722-34. PubMed ID: 15986197 [TBL] [Abstract][Full Text] [Related]
3. Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats. Forget B; Barthélémy S; Saurini F; Hamon M; Thiébot MH Psychopharmacology (Berl); 2006 Nov; 189(1):59-69. PubMed ID: 16969683 [TBL] [Abstract][Full Text] [Related]
4. Post-retrieval disruption of a cocaine conditioned place preference by systemic and intrabasolateral amygdala beta2- and alpha1-adrenergic antagonists. Bernardi RE; Ryabinin AE; Berger SP; Lattal KM Learn Mem; 2009 Dec; 16(12):777-89. PubMed ID: 19940038 [TBL] [Abstract][Full Text] [Related]
5. Cannabinoid CB1 receptor antagonist rimonabant disrupts nicotine reward-associated memory in rats. Fang Q; Li FQ; Li YQ; Xue YX; He YY; Liu JF; Lu L; Wang JS Pharmacol Biochem Behav; 2011 Oct; 99(4):738-42. PubMed ID: 21722663 [TBL] [Abstract][Full Text] [Related]
6. Nicotine place preference in a biased conditioned place preference design. Brielmaier JM; McDonald CG; Smith RF Pharmacol Biochem Behav; 2008 Mar; 89(1):94-100. PubMed ID: 18086490 [TBL] [Abstract][Full Text] [Related]
7. Modulation of nicotine-induced attentional enhancement in rats by adrenoceptor antagonists. Hahn B; Stolerman IP Psychopharmacology (Berl); 2005 Feb; 177(4):438-47. PubMed ID: 15252705 [TBL] [Abstract][Full Text] [Related]
8. Naltrexone attenuation of conditioned but not primary reinforcement of nicotine in rats. Liu X; Palmatier MI; Caggiula AR; Sved AF; Donny EC; Gharib M; Booth S Psychopharmacology (Berl); 2009 Mar; 202(4):589-98. PubMed ID: 18807246 [TBL] [Abstract][Full Text] [Related]
9. Involvement of alpha1-adrenergic receptors in tranylcypromine enhancement of nicotine self-administration in rat. Villégier AS; Lotfipour S; Belluzzi JD; Leslie FM Psychopharmacology (Berl); 2007 Sep; 193(4):457-65. PubMed ID: 17486319 [TBL] [Abstract][Full Text] [Related]
10. Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction. Forget B; Wertheim C; Mascia P; Pushparaj A; Goldberg SR; Le Foll B Neuropsychopharmacology; 2010 Jul; 35(8):1751-60. PubMed ID: 20357760 [TBL] [Abstract][Full Text] [Related]
11. Individual variation in the motivational properties of a nicotine cue: sign-trackers vs. goal-trackers. Yager LM; Robinson TE Psychopharmacology (Berl); 2015 Sep; 232(17):3149-60. PubMed ID: 25980485 [TBL] [Abstract][Full Text] [Related]
12. Nicotine induces a conditioned place preference in male Japanese quail (Coturnix japonica). Bolin BL; Cornett HL; Barnes AF; Gill KE; Akins CK Physiol Behav; 2012 Oct; 107(3):364-7. PubMed ID: 22939765 [TBL] [Abstract][Full Text] [Related]
14. The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions. Pak AC; Ashby CR; Heidbreder CA; Pilla M; Gilbert J; Xi ZX; Gardner EL Int J Neuropsychopharmacol; 2006 Oct; 9(5):585-602. PubMed ID: 16942635 [TBL] [Abstract][Full Text] [Related]
15. Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats. Belluzzi JD; Lee AG; Oliff HS; Leslie FM Psychopharmacology (Berl); 2004 Jul; 174(3):389-95. PubMed ID: 14740150 [TBL] [Abstract][Full Text] [Related]
17. Drug-free and context-dependent locomotor hyperactivity in DBA/2 J mice previously treated with repeated cocaine: Relationship with behavioral sensitization and role of noradrenergic receptors. Luján MA; Colomar L; Tarragón E; López-Cruz L; Pastor R; Font L Pharmacol Biochem Behav; 2019 Jan; 176():101-110. PubMed ID: 30571988 [TBL] [Abstract][Full Text] [Related]